Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Role of gonadotropin-releasing hormone (GnRH) in ovarian cancer.

Gründker C, Emons G.

Reprod Biol Endocrinol. 2003 Oct 7;1:65. Review.

2.
3.

Biology of the gonadotropin-releasing hormone system in gynecological cancers.

Gründker C, Günthert AR, Westphalen S, Emons G.

Eur J Endocrinol. 2002 Jan;146(1):1-14. Review.

4.
7.

GnRH-II antagonists induce apoptosis in human endometrial, ovarian, and breast cancer cells via activation of stress-induced MAPKs p38 and JNK and proapoptotic protein Bax.

Fister S, Günthert AR, Aicher B, Paulini KW, Emons G, Gründker C.

Cancer Res. 2009 Aug 15;69(16):6473-81. doi: 10.1158/0008-5472.CAN-08-4657. Epub 2009 Jul 28.

9.

GnRH antagonists in the treatment of gynecological and breast cancers.

Emons G, Gründker C, Günthert AR, Westphalen S, Kavanagh J, Verschraegen C.

Endocr Relat Cancer. 2003 Jun;10(2):291-9. Review.

10.
11.
12.
14.

Effects of LHRH-analogues on mitogenic signal transduction in cancer cells.

Emons G, Müller V, Ortmann O, Schulz KD.

J Steroid Biochem Mol Biol. 1998 Apr;65(1-6):199-206. Review.

PMID:
9699874
16.

Autoregulation of the gonadotropin-releasing hormone (GnRH) system during puberty: effects of antagonistic versus agonistic GnRH analogs in a female rat model.

Roth C, Schricker M, Lakomek M, Strege A, Heiden I, Luft H, Munzel U, Wuttke W, Jarry H.

J Endocrinol. 2001 May;169(2):361-71.

18.
19.

Luteinizing hormone-releasing hormone induces JunD-DNA binding and extends cell cycle in human ovarian cancer cells.

Günthert AR, Gründker C, Hollmann K, Emons G.

Biochem Biophys Res Commun. 2002 May 31;294(1):11-5.

PMID:
12054733
20.

Supplemental Content

Support Center